Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Jason Crowner

Vascular Surgery Chapel Hill, NC Medical Doctor

NPI 1912224866 CMS profile 1393345

101 Manning Dr, Vascular Surgery Cb7212, Chapel Hill, NC 27514

Open in the dashboard

General payments

$1,822

50 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$3,160 paid to institutions, not to them · program years 2019–2021

Through program year 2025, Jason Crowner of Chapel Hill, NC is reported in the CMS Open Payments database as having received $1,822 across 50 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $3,160 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 29th percentile of Vascular Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $166 7
2024 General $507 18
2023 General $147 6
2022 General $516 9
2021 General $219 5
2020 General $22 1
2019 General $246 4

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Jason Crowner
  • Vascular Surgery median
  • Middle half of Vascular Surgery
  • National median

In program year 2025, general payments to Jason Crowner were reported at $166. Among 3,991 Vascular Surgery profiles paid that year, the median was $924 and the middle half received between $273 and $2,636.

Show as a table
Year Jason Crowner Vascular Surgery median Middle half National median
2019 $246 $796 $226–$2,363 $163
2020 $22 $348 $118–$1,110 $114
2021 $219 $471 $158–$1,421 $132
2022 $516 $725 $222–$2,183 $149
2023 $147 $836 $257–$2,440 $160
2024 $507 $909 $252–$2,619 $164
2025 $166 $924 $273–$2,636 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Cook Medical LLC $506 12 payments
  2. Inari Medical, Inc. $238 12 payments
  3. Medtronic Vascular, Inc. $150 1 payment
  4. Integra LifeSciences Corporation $140 1 payment
  5. Bolton Medical Inc $128 1 payment
  6. Abbott Laboratories $93 4 payments
  7. Cardiovascular Systems Inc. $80 3 payments
  8. W. L. Gore & Associates, Inc. $74 1 payment
  9. Cordis US Corp. $59 1 payment
  10. Ethicon US, LLC $52 2 payments
  11. Other $301 12 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $1,822 50 payments
Products named General payments · program years 2019–2025
  1. FLOWTRIEVER CATHETER, S $255 13 payments
  2. CT THROMBECTOMY SYSTEM KIT $255 13 payments
  3. Zenith Spiral-Z $184 7 payments
  4. Endurant $150 1 payment
  5. Integra Recon-Skin And Wound $140 1 payment
  6. Integra Recon-Skin And Wound $140 1 payment
  7. Integra Recon-Skin And Wound $140 1 payment
  8. INTEGRA DERMAL REGENERATION TEMPLATE $140 1 payment
  9. PRIMATRIX $140 1 payment
  10. TREO ABDOMINAL STENT-GRAFT SYSTEM $128 1 payment
  11. Other $947 27 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 104 billing codes

Paid by Medicare

$234,173

Medicare's payments for the services billed

Medicare patients

808

Average age 73

Services billed

1,960

446 women, 362 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 61%
Diabetes 60%
Chronic kidney disease 60%
Ischemic heart disease 55%
Heart failure 54%
Atrial fibrillation 33%
COPD 32%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

50 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record